Kaylene J Simpson Selected Research

Fluorouracil (Carac)

10/2021

SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than TP53 Mutation Status.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kaylene J Simpson Research Topics

Disease

28	Neoplasms (Cancer) 04/2023 - 08/2004
12	Breast Neoplasms (Breast Cancer) 04/2023 - 09/2004
7	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 12/2017
3	Neuroblastoma 05/2024 - 12/2017
3	Ovarian Neoplasms (Ovarian Cancer) 11/2021 - 10/2002
3	Carcinoma (Carcinomatosis) 01/2018 - 12/2005
2	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2022 - 10/2020
2	Carcinogenesis 01/2022 - 10/2018
2	Neoplasm Metastasis (Metastasis) 01/2018 - 09/2009
2	Virus Diseases (Viral Diseases) 10/2017 - 03/2016
2	Henipavirus Infections 10/2016 - 03/2016
2	Infections 10/2016 - 03/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2023
1	Leukemia 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Endometriosis 01/2023
1	Immune System Diseases (Immune Disorders) 12/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2021
1	Hematologic Neoplasms (Hematological Malignancy) 10/2021
1	Esophageal Neoplasms (Esophageal Cancer) 10/2021
1	Bites and Stings (Sting) 08/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	Genomic Instability 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2020
1	Triple Negative Breast Neoplasms 01/2019
1	Disease Progression 01/2018
1	Inflammation (Inflammations) 10/2017
1	Contact Dermatitis (Eczema, Contact) 10/2017

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 10/2021 - 08/2004
7	Small Interfering RNA (siRNA)IBA 01/2021 - 03/2013
6	MicroRNAs (MicroRNA)IBA 05/2024 - 10/2016
4	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2008
3	Androgen Receptors (Androgen Receptor)IBA 04/2024 - 11/2021
3	eprenetapoptIBA 09/2022 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2017
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 01/2016
2	Phenobarbital (Luminal)FDA Link 04/2023 - 01/2020
2	LigandsIBA 01/2023 - 01/2022
2	EnzymesIBA 09/2022 - 03/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 04/2020
2	CX 5461IBA 11/2021 - 01/2021
2	RNA Polymerase I (Polymerase I, RNA)IBA 11/2021 - 01/2021
2	Docetaxel (Taxotere)FDA Link 04/2020 - 01/2018
2	Cadherins (E-Cadherin)IBA 01/2020 - 05/2015
1	Glycerophospholipids (Phosphoglycerides)IBA 12/2023
1	ProteomeIBA 12/2023
1	Ether (Diethyl Ether)IBA 12/2023
1	Glycoproteins (Glycoprotein)IBA 12/2023
1	LipidsIBA 12/2023
1	Hormones (Hormone)IBA 04/2023
1	CopperIBA 04/2023
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2023
1	Vascular Endothelial Growth Factor CIBA 01/2023
1	Estrogens (Estrogen)FDA Link 01/2023
1	Butyrates (Butyrate)IBA 12/2022
1	palbociclibIBA 12/2022
1	Glutathione (Reduced Glutathione)IBA 09/2022
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 09/2022
1	Serine (L-Serine)FDA Link 09/2022
1	Vincristine (Oncovin)FDA LinkGeneric 01/2022
1	AndrogensIBA 01/2022
1	Histocompatibility Antigens Class IIBA 01/2022
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	talazoparibIBA 11/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2021
1	Cisplatin (Platino)FDA LinkGeneric 10/2021
1	2,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA 10/2021
1	Fluorouracil (Carac)FDA LinkGeneric 10/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2021
1	Phosphotransferases (Kinase)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	Viral DNAIBA 08/2021
1	Interferon Type IIBA 08/2021
1	multidrug resistance-associated protein 1IBA 01/2021
1	Sulfhydryl Compounds (Thiols)IBA 01/2021
1	VemurafenibIBA 10/2020
1	eribulin FDA Link 04/2020
1	AnthracyclinesIBA 04/2020
1	Epirubicin (Ellence)FDA LinkGeneric 04/2020
1	Alkylating AgentsIBA 04/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2020
1	Poly AIBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	src-Family KinasesIBA 01/2019
1	TetraspaninsIBA 10/2018
1	Monomeric GTP-Binding ProteinsIBA 10/2018
1	cabazitaxel FDA Link 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	taxaneIBA 01/2018
1	MethyltransferasesIBA 03/2016

Therapy/Procedure

17	Therapeutics 01/2023 - 04/2012
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
3	Castration 04/2024 - 01/2018
1	Radiotherapy 01/2023
1	Immunotherapy 01/2022